Documents

Displaying 21 - 40 of 127 results
 
Collapse Filters
 
Expand Filters         +
June 5, 2020

Inhalants - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the type of drugs referred to as inhalants - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Hydromorphone - Drug Fact Sheet

DEA's revised and updated drug fact sheet about a drug known as hydromorphone - what it is, what is its origin, what are its common street names, what it looks like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Heroin - Drug Fact Sheet

DEA's revised and updated drug fact sheet about heroin - what it is, what is its history, what are its common street names, what it looks like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Hallucinogens - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as hallucinogens - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

GHB - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the drug known as GHB - what it is, what is its origin, what are its common street names, what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Fentanyl - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as fentanyls - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Ecstasy - MDMA Drug Fact Sheet

DEA's revised and updated drug fact sheet about MDMA, also known as ecstasy - what it is, what is its origin, what common street names for these drugs, what does it look like, how it is abused, what their effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

DXM - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the drug known as DXM - what is it, what is its origin, what are common street names , what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Depressants - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as depressants - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Cocaine - Drug Fact Sheet

DEA's revised and updated drug fact sheet about cocaine - what it is, its origin, what are common street names, what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Benzodiazpines - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as benzodiazepines (tranquilizers) - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Bath Salts - Drug Fact Sheet

DEA's revised and updated drug fact sheet about synthetic stimulants known by the street name "bath salts" - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Barbiturates - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as barbiturates - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Amphetamines - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as amphetamines - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

May 15, 2020

Latent Print Examination Manual 2020

This document is an internal Drug Enforcement Administration quality system document for latent print examination.  The document is updated periodically and current as of May 15, 2020 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only and inclusion does not imply endorsement by the Drug Enforcement Administration.

April 13, 2020

Drugs of Abuse

Drugs of Abuse delivers clear, scientific information about drugs in a factual, straightforward way. With the information in this guide, parents and caregivers can help their children make smart choices and avoid the consequences of drug abuse. This publication covers topics including the Controlled Substances Act and introduces drug classes including narcotics, stimulants, marijuana/cannabis, inhalants, steroids, and more. 

March 6, 2020

Fentanyl Flow to the United States

The flow of fentanyl into the United States in 2019 is more diverse compared to the start of the fentanyl crisis in 2014, with new source countries and new transit countries emerging as significant trafficking nodes. This is exacerbating the already multi-faceted fentanyl crisis by introducing additional source countries into the global supply chain of fentanyl, fentanyl-related substances, and fentanyl precursors. Further, this complicates law enforcement operations and policy efforts to stem the flow of fentanyl into the United States. While Mexico and China are the primary source countries for fentanyl and fentanyl-related substances trafficked directly into the United States, India is emerging as a source for finished fentanyl powder and fentanyl precursor chemicals.

February 26, 2020

NFLIS Findings for Synthetic Cannabinoid Substance in New Orleans

The DEA New Orleans Division conducted a five-year review of the data on synthetic substances reported in the National Forensic Laboratory Information System for their area of responsibility. The findings revealed that Louisiana submitted the majority of reports for synthetic cannabinoid substance and synthetic cathinones substance for 2013 to 2017. Synthetic cannabinoid substance and synthetic cathinones are classified as new psychoactive substances (NPS).

January 30, 2020

2019 National Drug Threat Assessment

The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. The report combines federal, state, local, and tribal law enforcement reporting; public health data; open source reporting; and intelligence from other government agencies to determine which substances and criminal organizations represent the greatest threat to the United States.

January 21, 2020

DEA 360 Strategy Reach and Impact Report: NEWARK

This report describes the methods and results of an assessment of the reach and impact of community outreach activities of the DEA 360 Strategy in Newark. Results are based on a summary of metrics compiled from each program facilitator, as well as from interviews with community partners from across the region.

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice